Updated

The Federal Trade Commission and seven state attorneys general asked a federal court to hold former pharmaceutical executive Martin Shkreli in contempt for allegedly violating a 2022 lifetime ban from the pharmaceutical industry. The agencies cited evidence showing that Shkreli repeatedly breached the court order that was intended to prevent his involvement in drug pricing schemes and predatory pharmaceutical practices.